Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited12.67336256349998.0754
Domestic EquitiesLupin Limited7.88362883991620.8656
Domestic EquitiesDivi's Laboratories Limited6.5367850754514.7912
Domestic EquitiesDr. Reddy's Laboratories Limited6.05703916074477.0170
Domestic EquitiesCipla Limited5.87583495054462.7451
Domestic EquitiesApollo Hospitals Enterprise Limited5.7342648795451.5938
Domestic EquitiesMedPlus Health Services Limited3.67983627277289.8013
Domestic EquitiesVijaya Diagnostic Centre Limited3.51412886684276.7464
Domestic EquitiesAjanta Pharma Limited3.3887959323266.8741
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.7849913226219.3204
Domestic EquitiesSai Life Sciences Limited2.71022555745213.4430
Domestic EquitiesAurobindo Pharma Limited2.61101702630205.6266
Domestic EquitiesAbbott India Limited2.596674187204.4965
Domestic EquitiesIPCA Laboratories Limited2.54881364742200.7263
Domestic EquitiesMankind Pharma Limited2.4466907154192.6795
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.3730999649186.8844
Domestic EquitiesThyrocare Technologies Limited2.34234392120184.4690
Domestic EquitiesAlkem Laboratories Limited2.3334323678183.7682
Domestic EquitiesDr. Lal Path Labs Limited2.18031218224171.7087
Domestic EquitiesNarayana Hrudayalaya Limited2.0740923911163.3382
Domestic EquitiesGland Pharma Limited1.8771800549147.8294
Domestic EquitiesPfizer Limited1.8442318249145.2361
Domestic EquitiesMax Healthcare Institute Limited1.50811241340118.7714
Domestic EquitiesEmcure Pharmaceuticals Limited1.3872746337109.2488
Domestic EquitiesSuraksha Diagnostic Limited1.31583896349103.6234
Domestic EquitiesFortis Healthcare Limited1.1935110388993.9961
Domestic EquitiesSanofi India Limited1.174823027292.5164
Domestic EquitiesSanofi Consumer Healthcare India Limited1.152221365990.7367
Domestic EquitiesSyngene International Limited1.1322188337289.1682
Domestic EquitiesBiocon Limited1.0337221937481.4066
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.8457151526466.6034
Domestic EquitiesAnthem Biosciences Limited0.8055105850363.4361
Domestic EquitiesAstraZeneca Pharma India Limited0.67936256853.4956
Domestic EquitiesIndoco Remedies Limited0.5068183492439.9114
Domestic EquitiesConcord Biotech Limited0.166711173813.1314
Total 98.9674 7794.0817
Cash & Cash Equivalents and Net AssetsTriparty Repo1.1532 90.8167
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0008 0.0651
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.1214 -9.5590
Total 1.0326 81.3228
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.